Literature DB >> 20395291

Conserved water-mediated hydrogen bond network between TM-I, -II, -VI, and -VII in 7TM receptor activation.

Rie Nygaard1, Louise Valentin-Hansen, Jacek Mokrosinski, Thomas M Frimurer, Thue W Schwartz.   

Abstract

Five highly conserved polar residues connected by a number of structural water molecules together with two rotamer micro-switches, TrpVI:13 and TyrVII:20, constitute an extended hydrogen bond network between the intracellular segments of TM-I, -II, -VI, and -VII of 7TM receptors. Molecular dynamics simulations showed that, although the fewer water molecules in rhodopsin were relatively movable, the hydrogen bond network of the beta2-adrenergic receptor was fully loaded with water molecules that were surprisingly immobilized between the two rotamer switches, both apparently being in their closed conformation. Manipulations of the rotamer state of TyrVII:20 and TrpVI:13 demonstrated that these residues served as gates for the water molecules at the intracellular and extracellular ends of the hydrogen bond network, respectively. TrpVI:13 at the bottom of the main ligand-binding pocket was shown to apparently function as a catching trap for water molecules. Mutational analysis of the beta2-adrenergic receptor demonstrated that the highly conserved polar residues of the hydrogen bond network were all important for receptor signaling but served different functions, some dampening constitutive activity (AsnI:18, AspII:10, and AsnVII:13), whereas others (AsnVII:12 and AsnVII:16) located one helical turn apart and sharing a water molecule were shown to be essential for agonist-induced signaling. It is concluded that the conserved water hydrogen bond network of 7TM receptors constitutes an extended allosteric interface between the transmembrane segments being of crucial importance for receptor signaling and that part of the function of the rotamer micro-switches, TyrVII:20 and TrpVI:13, is to gate or trap the water molecules.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20395291      PMCID: PMC2885241          DOI: 10.1074/jbc.M110.106021

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

Review 1.  Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin.

Authors:  Tara Mirzadegan; Gil Benkö; Sławomir Filipek; Krzysztof Palczewski
Journal:  Biochemistry       Date:  2003-03-18       Impact factor: 3.162

Review 2.  Rhodopsin structure, dynamics, and activation: a perspective from crystallography, site-directed spin labeling, sulfhydryl reactivity, and disulfide cross-linking.

Authors:  Wayne L Hubbell; Christian Altenbach; Cheryl M Hubbell; H Gobind Khorana
Journal:  Adv Protein Chem       Date:  2003

3.  Molecular dynamics simulation of dark-adapted rhodopsin in an explicit membrane bilayer: coupling between local retinal and larger scale conformational change.

Authors:  Paul S Crozier; Mark J Stevens; Lucy R Forrest; Thomas B Woolf
Journal:  J Mol Biol       Date:  2003-10-24       Impact factor: 5.469

4.  The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure.

Authors:  Tetsuji Okada; Minoru Sugihara; Ana-Nicoleta Bondar; Marcus Elstner; Peter Entel; Volker Buss
Journal:  J Mol Biol       Date:  2004-09-10       Impact factor: 5.469

5.  The ring of the rhodopsin chromophore in a hydrophobic activation switch within the binding pocket.

Authors:  Paul J R Spooner; Jonathan M Sharples; Scott C Goodall; Petra H M Bovee-Geurts; Michiel A Verhoeven; Johan Lugtenburg; Arthur M A Pistorius; Willem J Degrip; Anthony Watts
Journal:  J Mol Biol       Date:  2004-10-22       Impact factor: 5.469

6.  Activation of the CXCR3 chemokine receptor through anchoring of a small molecule chelator ligand between TM-III, -IV, and -VI.

Authors:  Mette M Rosenkilde; Michael B Andersen; Rie Nygaard; Thomas M Frimurer; Thue W Schwartz
Journal:  Mol Pharmacol       Date:  2006-12-14       Impact factor: 4.436

7.  Structure of bovine rhodopsin in a trigonal crystal form.

Authors:  Jade Li; Patricia C Edwards; Manfred Burghammer; Claudio Villa; Gebhard F X Schertler
Journal:  J Mol Biol       Date:  2004-11-05       Impact factor: 5.469

8.  Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switch.

Authors:  Lei Shi; George Liapakis; Rui Xu; Frank Guarnieri; Juan A Ballesteros; Jonathan A Javitch
Journal:  J Biol Chem       Date:  2002-08-06       Impact factor: 5.157

9.  Membrane model for the G-protein-coupled receptor rhodopsin: hydrophobic interface and dynamical structure.

Authors:  Thomas Huber; Ana V Botelho; Klaus Beyer; Michael F Brown
Journal:  Biophys J       Date:  2004-04       Impact factor: 4.033

10.  The probable arrangement of the helices in G protein-coupled receptors.

Authors:  J M Baldwin
Journal:  EMBO J       Date:  1993-04       Impact factor: 11.598

View more
  26 in total

1.  Structural basis of activation of bitter taste receptor T2R1 and comparison with Class A G-protein-coupled receptors (GPCRs).

Authors:  Nisha Singh; Sai Prasad Pydi; Jasbir Upadhyaya; Prashen Chelikani
Journal:  J Biol Chem       Date:  2011-08-18       Impact factor: 5.157

2.  Evolution of nonspectral rhodopsin function at high altitudes.

Authors:  Gianni M Castiglione; Frances E Hauser; Brian S Liao; Nathan K Lujan; Alexander Van Nynatten; James M Morrow; Ryan K Schott; Nihar Bhattacharyya; Sarah Z Dungan; Belinda S W Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-22       Impact factor: 11.205

3.  Critical hydrogen bond formation for activation of the angiotensin II type 1 receptor.

Authors:  Jérôme Cabana; Brian Holleran; Marie-Ève Beaulieu; Richard Leduc; Emanuel Escher; Gaétan Guillemette; Pierre Lavigne
Journal:  J Biol Chem       Date:  2012-12-07       Impact factor: 5.157

4.  Probing the metabotropic glutamate receptor 5 (mGlu₅) positive allosteric modulator (PAM) binding pocket: discovery of point mutations that engender a "molecular switch" in PAM pharmacology.

Authors:  Karen J Gregory; Elizabeth D Nguyen; Sean D Reiff; Emma F Squire; Shaun R Stauffer; Craig W Lindsley; Jens Meiler; P Jeffrey Conn
Journal:  Mol Pharmacol       Date:  2013-02-26       Impact factor: 4.436

5.  Can Specific Protein-Lipid Interactions Stabilize an Active State of the Beta 2 Adrenergic Receptor?

Authors:  Chris Neale; Henry D Herce; Régis Pomès; Angel E García
Journal:  Biophys J       Date:  2015-10-20       Impact factor: 4.033

6.  Evidence from Chlamydomonas on the photoactivation of rhodopsins without isomerization of their chromophore.

Authors:  Kenneth W Foster; Jureepan Saranak; Sonja Krane; Randy L Johnson; Koji Nakanishi
Journal:  Chem Biol       Date:  2011-06-24

7.  Calcium-sensing receptor residues with loss- and gain-of-function mutations are located in regions of conformational change and cause signalling bias.

Authors:  Caroline M Gorvin; Morten Frost; Tomas Malinauskas; Treena Cranston; Hannah Boon; Christian Siebold; E Yvonne Jones; Fadil M Hannan; Rajesh V Thakker
Journal:  Hum Mol Genet       Date:  2018-11-01       Impact factor: 6.150

8.  Retinal ligand mobility explains internal hydration and reconciles active rhodopsin structures.

Authors:  Nicholas Leioatts; Blake Mertz; Karina Martínez-Mayorga; Tod D Romo; Michael C Pitman; Scott E Feller; Alan Grossfield; Michael F Brown
Journal:  Biochemistry       Date:  2014-01-08       Impact factor: 3.162

9.  The arginine of the DRY motif in transmembrane segment III functions as a balancing micro-switch in the activation of the β2-adrenergic receptor.

Authors:  Louise Valentin-Hansen; Marleen Groenen; Rie Nygaard; Thomas M Frimurer; Nicholas D Holliday; Thue W Schwartz
Journal:  J Biol Chem       Date:  2012-07-26       Impact factor: 5.157

10.  Structure-Activity Analysis of Biased Agonism at the Human Adenosine A3 Receptor.

Authors:  Jo-Anne Baltos; Silvia Paoletta; Anh T N Nguyen; Karen J Gregory; Dilip K Tosh; Arthur Christopoulos; Kenneth A Jacobson; Lauren T May
Journal:  Mol Pharmacol       Date:  2016-05-02       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.